Form 8-K - Current report:
SEC Accession No. 0001493152-24-037027
Filing Date
2024-09-18
Accepted
2024-09-18 17:21:11
Documents
15
Period of Report
2024-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46076
2 ex2-1.htm EX-2.1 42973
  Complete submission text file 0001493152-24-037027.txt   272131

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE invo-20240912.xsd EX-101.SCH 3033
4 XBRL LABEL FILE invo-20240912_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE invo-20240912_pre.xml EX-101.PRE 24177
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3559
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

EIN.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 241308344
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)